Other
Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
West Pharmaceutical Services Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax decreased by 800.0% to -$700.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from -$400.00K to -$700.00K. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2023
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Frequent or large reclassifications may indicate volatility in the company's hedging strategy or unexpected changes in underlying market exposures.
Detailed definition
The amount of gain or loss on cash flow hedges that is reclassified out of accumulated other comprehensive income and in...
Peer comparison
Standard disclosure for companies utilizing derivatives to manage interest rate or commodity price risks.
Metric ID:
other_other_comprehensive_income_loss_cash_flow_hedge_re_fc8aacHistorical Data
8 periods
| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | -$1.20M | -$1.20M | -$1.30M | -$500.00K | -$400.00K | $100.00K | $100.00K | -$700.00K |
| QoQ Change | — | +0.0% | -8.3% | +61.5% | +20.0% | +125.0% | +0.0% | -800.0% |
| YoY Change | — | — | — | +58.3% | +66.7% | +107.7% | +120.0% | -75.0% |
Range-$1.30M – $100.00K
CAGR-26.5%
Avg YoY Growth+55.5%
Median YoY Growth+66.7%
Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other comprehensive income loss cash flow hedge reclassification for discontinuance before tax?
- West Pharmaceutical Services (WST) reported other comprehensive income loss cash flow hedge reclassification for discontinuance before tax of -$700.00K in Q1 2026.
- How has West Pharmaceutical Services's other comprehensive income loss cash flow hedge reclassification for discontinuance before tax changed year-over-year?
- West Pharmaceutical Services's other comprehensive income loss cash flow hedge reclassification for discontinuance before tax decreased by 75.0% year-over-year, from -$400.00K to -$700.00K.
- What does other comprehensive income loss cash flow hedge reclassification for discontinuance before tax mean?
- Gains or losses from discontinued cash flow hedges moved from equity to the income statement.